Evaluation of Muscle Mass from Chest CT versus Body Mass Index in Determining Severity and Outcomes in Non-Cystic Fibrosis Bronchiectasis - Takeaways - MDSpire

Evaluation of Muscle Mass from Chest CT versus Body Mass Index in Determining Severity and Outcomes in Non-Cystic Fibrosis Bronchiectasis

  • By

  • Ping-Huai Wang

  • Shih-Lung Cheng

  • Chin-Chung Shu

  • Hao-Chien Wang

  • February 14, 2026

  • 0 min

Share

  • 1

    Bronchiectasis is a chronic respiratory disease requiring effective airway clearance and adequate nutritional status to prevent muscle wasting.

  • 2

    Body Mass Index (BMI) is a common but limited measure for assessing nutritional status in chronic airway diseases like bronchiectasis.

  • 3

    CT-derived muscle mass, particularly the L1 muscle index (L1MI), may provide valuable insights into muscle status and disease outcomes in bronchiectasis.

  • 4

    This study investigates the correlation between L1MI, clinical characteristics, and outcomes in patients with bronchiectasis.

  • 5

    The research aims to address the gap in understanding risk factors for low muscle mass and its impact on bronchiectasis outcomes.

Original Source(s)

Evaluation of Muscle Mass from Chest CT versus Body Mass Index in Determining Severity and Outcomes in Non-Cystic Fibrosis Bronchiectasis

  • by Ping-Huai Wang, Shih-Lung Cheng, Chin-Chung Shu, Hao-Chien Wang

  • February 14, 2026

Related Content

AMA Backs Structured Vaccine Review

Medical societies and public health groups will collaborate on policy questions and evidence briefs for the 2026 to 2027 respiratory virus season.

Inflammatory Biomarkers and Respiratory Function in Liver Transplant Patients: Findings from a Nationwide Cohort Analysis

Extended Viral PCR: Does It Help?

Researchers evaluate whether extended viral PCR testing is associated with antibiotic use and length of stay in adult inpatients.